201 related articles for article (PubMed ID: 35158230)
1. LSD, afterglow and hangover: Increased episodic memory and verbal fluency, decreased cognitive flexibility.
Wießner I; Olivieri R; Falchi M; Palhano-Fontes F; Oliveira Maia L; Feilding A; B Araujo D; Ribeiro S; Tófoli LF
Eur Neuropsychopharmacol; 2022 May; 58():7-19. PubMed ID: 35158230
[TBL] [Abstract][Full Text] [Related]
2. LSD acutely impairs working memory, executive functions, and cognitive flexibility, but not risk-based decision-making.
Pokorny T; Duerler P; Seifritz E; Vollenweider FX; Preller KH
Psychol Med; 2020 Oct; 50(13):2255-2264. PubMed ID: 31500679
[TBL] [Abstract][Full Text] [Related]
3. LSD and language: Decreased structural connectivity, increased semantic similarity, changed vocabulary in healthy individuals.
Wießner I; Falchi M; Daldegan-Bueno D; Palhano-Fontes F; Olivieri R; Feilding A; B Araujo D; Ribeiro S; Bezerra Mota N; Tófoli LF
Eur Neuropsychopharmacol; 2023 Mar; 68():89-104. PubMed ID: 36669231
[TBL] [Abstract][Full Text] [Related]
4. LSD and creativity: Increased novelty and symbolic thinking, decreased utility and convergent thinking.
Wießner I; Falchi M; Maia LO; Daldegan-Bueno D; Palhano-Fontes F; Mason NL; Ramaekers JG; Gross ME; Schooler JW; Feilding A; Ribeiro S; Araujo DB; Tófoli LF
J Psychopharmacol; 2022 Mar; 36(3):348-359. PubMed ID: 35105186
[TBL] [Abstract][Full Text] [Related]
5. Role of the 5-HT
Preller KH; Schilbach L; Pokorny T; Flemming J; Seifritz E; Vollenweider FX
J Neurosci; 2018 Apr; 38(14):3603-3611. PubMed ID: 29555857
[TBL] [Abstract][Full Text] [Related]
6. Low-dose LSD and the stream of thought: Increased Discontinuity of Mind, Deep Thoughts and abstract flow.
Wießner I; Falchi M; Palhano-Fontes F; Oliveira Maia L; Feilding A; Ribeiro S; Bezerra Mota N; Araujo DB; Tófoli LF
Psychopharmacology (Berl); 2022 Jun; 239(6):1721-1733. PubMed ID: 34708255
[TBL] [Abstract][Full Text] [Related]
7. Modulation of long-term potentiation following microdoses of LSD captured by thalamo-cortical modelling in a randomised, controlled trial.
Murphy RJ; Godfrey K; Shaw AD; Muthukumaraswamy S; Sumner RL
BMC Neurosci; 2024 Feb; 25(1):7. PubMed ID: 38317077
[TBL] [Abstract][Full Text] [Related]
8. The paradoxical psychological effects of lysergic acid diethylamide (LSD).
Carhart-Harris RL; Kaelen M; Bolstridge M; Williams TM; Williams LT; Underwood R; Feilding A; Nutt DJ
Psychol Med; 2016 May; 46(7):1379-90. PubMed ID: 26847689
[TBL] [Abstract][Full Text] [Related]
9. Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers.
Family N; Maillet EL; Williams LTJ; Krediet E; Carhart-Harris RL; Williams TM; Nichols CD; Goble DJ; Raz S
Psychopharmacology (Berl); 2020 Mar; 237(3):841-853. PubMed ID: 31853557
[TBL] [Abstract][Full Text] [Related]
10. Relationship of Depression With Executive Functions and Visuospatial Memory in Elderly.
Klojčnik M; Kavcic V; Bakracevic Vukman K
Int J Aging Hum Dev; 2017 Dec; 85(4):490-503. PubMed ID: 28592136
[TBL] [Abstract][Full Text] [Related]
11. Effects of a diet integration with an oily emulsion of DHA-phospholipids containing melatonin and tryptophan in elderly patients suffering from mild cognitive impairment.
Rondanelli M; Opizzi A; Faliva M; Mozzoni M; Antoniello N; Cazzola R; Savarè R; Cerutti R; Grossi E; Cestaro B
Nutr Neurosci; 2012 Mar; 15(2):46-54. PubMed ID: 22334085
[TBL] [Abstract][Full Text] [Related]
12. Acute Subjective and Behavioral Effects of Microdoses of Lysergic Acid Diethylamide in Healthy Human Volunteers.
Bershad AK; Schepers ST; Bremmer MP; Lee R; de Wit H
Biol Psychiatry; 2019 Nov; 86(10):792-800. PubMed ID: 31331617
[TBL] [Abstract][Full Text] [Related]
13. Electroconvulsive therapy and cognitive functions in treatment-resistant depression.
Bodnar A; Krzywotulski M; Lewandowska A; Chlopocka-Wozniak M; Bartkowska-Sniatkowska A; Michalak M; Rybakowski JK
World J Biol Psychiatry; 2016; 17(2):159-64. PubMed ID: 26482837
[TBL] [Abstract][Full Text] [Related]
14. The acute effects of classic psychedelics on memory in humans.
Healy CJ
Psychopharmacology (Berl); 2021 Mar; 238(3):639-653. PubMed ID: 33420592
[TBL] [Abstract][Full Text] [Related]
15. LSD, madness and healing: Mystical experiences as possible link between psychosis model and therapy model.
Wießner I; Falchi M; Palhano-Fontes F; Feilding A; Ribeiro S; Tófoli LF
Psychol Med; 2023 Mar; 53(4):1151-1165. PubMed ID: 34253268
[TBL] [Abstract][Full Text] [Related]
16. Characterizing Thalamocortical (Dys)connectivity Following D-Amphetamine, LSD, and MDMA Administration.
Avram M; Müller F; Rogg H; Korda A; Andreou C; Holze F; Vizeli P; Ley L; Liechti ME; Borgwardt S
Biol Psychiatry Cogn Neurosci Neuroimaging; 2022 Sep; 7(9):885-894. PubMed ID: 35500840
[TBL] [Abstract][Full Text] [Related]
17. Statin Use and Cognitive Impairment in Patients With Type 1 Diabetes: An Observational Study.
Moryś JM; Kozera GM; Neubauer-Geryk J; Kruszewski P; Wolnik B; Nyka WM; Bieniaszewski L
Clin Neuropharmacol; 2016; 39(4):182-7. PubMed ID: 27046662
[TBL] [Abstract][Full Text] [Related]
18. Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study.
Hutten NRPW; Mason NL; Dolder PC; Theunissen EL; Holze F; Liechti ME; Feilding A; Ramaekers JG; Kuypers KPC
Eur Neuropsychopharmacol; 2020 Dec; 41():81-91. PubMed ID: 33082016
[TBL] [Abstract][Full Text] [Related]
19. Effective connectivity changes in LSD-induced altered states of consciousness in humans.
Preller KH; Razi A; Zeidman P; Stämpfli P; Friston KJ; Vollenweider FX
Proc Natl Acad Sci U S A; 2019 Feb; 116(7):2743-2748. PubMed ID: 30692255
[TBL] [Abstract][Full Text] [Related]
20. Acute Effects of Lysergic Acid Diethylamide on Circulating Steroid Levels in Healthy Subjects.
Strajhar P; Schmid Y; Liakoni E; Dolder PC; Rentsch KM; Kratschmar DV; Odermatt A; Liechti ME
J Neuroendocrinol; 2016 Mar; 28(3):12374. PubMed ID: 26849997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
